跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIO-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIO-TADALAFIL
Authorized
STANDARD
BIO-TADALAFIL
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2cd768b2b5975f3b
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
2cd768b2b5975f3b
Drug Approval Canada Name
BIO-TADALAFIL
Product Name
BIO-TADALAFIL
Status
Marketed
Status Date
2021-07-28
Original Market Date
2021-07-28
Din
02508729
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Atc Name
g 04 be 08
Aig Number
0149485002
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
TADALAFIL
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2cd768b2b5975f3b
Type
Standard
Back to Health Canada Approvals